Skip to main content
G Alexander, MD, Internal Medicine, Lutherville, MD

GCalebAlexanderMD

Internal Medicine • Lutherville, MD

Joint Appointment in Medicine

Join to view full profile

Dr. Alexander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alexander's full profile

Already have an account?

  • Office

    10753 Falls Road
    Pavilion II, Ste 325
    Lutherville, MD 21093
    Phone+1 410-583-2774
    Fax+1 410-583-2883

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1998

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2012 - 2026
  • IL State Medical License
    IL State Medical License 2001 - 2014
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Journal Articles

  • Characteristics of Copayment Offsets for Prescription Drugs in the United States  
    G Alexander, MD, JAMA Internal Medicine
  • Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic  
    Sumedha Gupta, G Caleb Alexander, JAMA Internal Medicine
  • Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program—Reply  
    G Alexander, MD, JAMA Internal Medicine

Authored Content

  • Moving Addiction Care to the Mainstream — Improving the Quality of Buprenorphine TreatmentJuly 2018

Press Mentions

  • Most First-Wave COVID-19 Clinical Trials Have ‘Major Design Shortcomings’
    Most First-Wave COVID-19 Clinical Trials Have ‘Major Design Shortcomings’June 16th, 2020

Grant Support

  • Televised Direct To Consumer Pharmaceutical Advertising And Patient OutcomesNational Heart, Lung, And Blood Institute2011
  • Assessing The Effect Of FDA Advisories On Provider, Patient, And Firm BehaviorAgency For Healthcare Research And Quality2010–2011
  • An RCT To Decrease Out-Of-Pocket Prescription CostsAgency For Healthcare Research And Quality2006–2010

Dr. G Alexander, Dr. G Alexander, MD, Dr. G Caleb Alexander